Open‐label study of etanercept treatment in patients with moderate‐to‐severe plaque psoriasis who lost a satisfactory response to adalimumab
J. Bagel; S. Tyring; K.C. Rice; D.H. Collier; G. Kricorian; J. Chung; J. Iles; B.S. Stolshek; A. Kaliyaperumal; K.A. Papp
Author Information: Psoriasis Treatment Center of Central New Jersey
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.